580 likes | 1.14k Vues
PEDIATRIC GERD. INTRODUCTION. Gastroesophageal reflux Gastroesophageal reflux disease. Mechanism and Pathophysiology of Reflux. Transient relaxation of the lower esophageal sphincter The short infant esophagus has limited volume Predominantly recumbent position of infants
E N D
INTRODUCTION Gastroesophageal reflux Gastroesophageal reflux disease
Mechanism and Pathophysiology of Reflux • Transient relaxation of the lower esophageal sphincter • The short infant esophagus has limited volume • Predominantly recumbent position of infants • Delayed emptying • Increased abdominal pressure
Prevalence of Regurgitation in Healthy Infants Infants (%) Age (months) Nelson et al. Arch Pediatr Adolesc Med.1997;151:569
Prevalence of GERD in infants • Premature infants (by pH-metry) >85% -3-10%: apnea, bradycardia, exacerbation of BPD • Infants <3 months (by Hx) 20-100% -33% receive medical attention -80% resolve with minimal intervention and no diagnostic evaluation bat
Genetic Predisposition for GERD • Familial clustering • Concordance for acid regurgitation • Proposed genetic links Chromosome 13 locus (13q14) Chromosome 9 locus
PRESENTING SYMPTOMS AND SIGNS OF GERD INFANTS -Feeding refusal -Recurrent vomiting -Poor weight gain -Irritability -Apnea or ALTE -Arching or head tilting (“pseudo-torticollis”) Rudolph et al. J Pediatr Gastroenterol Nutr. 2001;32:S1
PRESENTING SYMPTOMS AND SIGNS OF GERD • Preschool Intermittent vomiting or regurgitation Less commonly respiratory complica- tions Decreased food intake without any other complaints may be a symptom of esophagitis
Presenting Symptoms and Signs of GERD • Older Children and Adolescents Heartburn Chronic cough Regurgitation Nausea/epigastric Esophagitis pain Asthma Recurrent Pneumonia Hoarseness
Frequency of presenting symptoms in 76 children with GERD Percentage of subjects 63.9 34 29 22 18 16
Supraesophageal symptoms of GERD in children Apnea/bradycardia Chronic cough Wheezing/asthma Supra-esophageal manifestations of GERD Otitis/sinusitis Chronic sore throat Hoarseness Dental
LESS COMMON SIGNS AND SYMPTOMS IN CHILDREN • Hematemesis • Iron deficiency anemia • Failure to thrive/grow • Sandifer’s syndrome • (“pseudo-torticollis,” posturing
Taking a History for a child with Suspected GERD • History Feeding History Pattern of vomiting Past Medical History Psychosocial History Family History Growth Chart
Alarm and Signals Suggestive of Non-GERD Diagnoses • Recurrent vomiting • History and physical examination • Are there warning signals?
Common Nonreflux causes of Vomiting Infections Sepsis Meningitis Urinary tract infection Otitis media Obstruction Pyloric stenosis Malrotation Intussusception
Common Nonreflux causes of vomiting (continuation) Gastrointestinal Eosinophilic esophagitis Peptic ulcer disease Achalasia Pill esophagitis Gastroparesis Crohn disease Gastroenteritis Gall bladder disease Pancreatitis Celiac disease
Common Nonreflux Causes of Vomiting (continuation) Metabolic/Endocrine Galactosemia Fructose intolerance Urea cycle defects Diabetic ketoacidosis Toxic Lead poisoning
Common Nonreflux Causes of vomiting (continuation) Neurologic Hydrocephalus and shunt malfunctioning Subdural hematoma Intracranial hemorrhage Tumors Migraine
Common Nonreflux Causes of Vomiting (continuation) Allergic Dietary protein intolerance Respiratory Posttussive emesis Pneumonia Renal Obstructive uropathy Renal insufficiency
Common Nonreflux Causes of Vomiting Cardiac CHF and disease Recreational drugs and alcohol consumption Pregnancy Other Overfeeding Self-induced emesis
Diagnostic Approach to GER • History and Physical examination • Diagnostic studies Contrast Radiographs Esophageal ph monitoring Endoscopy Multichannel intraluminal impedance Scintigraphy
GOALS IN THE TREATMENT OF REFLUX • Eliminate symptoms quickly • Heal esophagitis • Manage or prevent complications • Maintain remission
Expert Recommendations forEmpiric Therapy in GERD • Empiric therapy can be used as a “test” to determine if GERD is causing a specific symptom -No gold standard test for GERD -Avoids invasive testing -Can have GERD despite normal diagnostic tesitng -Problem:placebo effect
Empiric Therapy in GERD (continuation) • Consideration for dose, duration, and type of medication -Severity of disease -Cost and insurance requirements -Risk of underlying conditions (eg. Asthma)
Empiric Therapy in GERD(continuation) • Define goals and length of empiric trial before initiation of therapy • Stop treatment if empiric therapy fails
Strategies for the Empiric Trial: Step-up Therapy • High-dose • PPI • PPI • H2Ra • Lifestyle • Modicifations* • Important to implement with medications as well • No studies evaluating these strategies in children
Management of Mild GERD Symptoms • Explanation and reassurance • Diet and lifestyle • Antacids
Lifestyle Management of Mild GERD Symptoms Infants • Normalize feeding volume and frequency • Consider thickened formula • Positioning -Upright after meals -Avoid car seats at home • Consider 2-4 week trial of hypoallergenic formula Rudolph CD, et al.Jpediatr Gastroenterol Nutr.2001:32(suppl2):S1
Lifestyle Management of Mild GERD Symptoms • Older Children and Adolescents • Avoid large meals (especially prior to exercising • Do not eat or drink 2 hours prior to bedtime • If obese, weight loss program • Limit food and drink that provoke GERD • Symptoms • Rudolph CD, et al. Jpediatr Gastroenterol Nutr,.2001:32(suppl 2):S1
Management of Mild-to-Moderate GERD Symptoms Prokinetics - Metoclopramide - Cisapride H2Receptor Antagonists - Cimetidine - Nizatidine - Famotidine - Ranitidine Proton Pump Inhibitors -Omeprazole -Lansoprazole
Acid Suppression Options for GERD in Children Therapy Medications Considerations Histamine2 Cimetidine -Available for receptor Famotidine infants,children antagonists Nizatidine and adolescents (H2RAs) Ranitidine -Less potent acid suppression compared with PPIs -Tolerance is an issue
Acid suppression Options for GERD in Children Therapy Medications Considerations Proton Esomeprazole -Available for Pump Lansoprazole children and Inhibitors Omeprazole adolescents (PPIs) -Superior efficacy to H2RA’s to H2RAs for healing and ph control -Cost and managed care restrictions
FDA Labeling for Rx H2RA Therapy for Pediatric GERD Indicated Ages Dosing Ranitidine 1 month to 5-10 mg/kg/day 16 years divided BID Famotidine 1 year to 1 mg/kg/day 16 years divided BID up to 40 mg. BID Nizatidine >12 years 150 mg. BID Cimetidine >16 years 800 mgBID or 400 mg. QID 3
PPIs Approved for Rx ofPediatric GERD (FDA Labeling) Omeprazole Weight Dosing Duration Indicated Ages <20 kg 10mg QD up to 2yrs-16yrs 12 wks >20 kg 20mg QD up tp 2yrs-16yrs Lansoprazole <30 kg 15 mg QD up to 12mo.-11yrs >30kg 30mg QD 12 wks 12mo-11yrs Nonerosive esophagitis-up to 8wks 12-17yrs
Importance of timing of PPIdose Dosing Administer PPI QD 30 min. before breakfast BID 30 min before breakfast and evening meal
H2RAs and Tachyphylaxis H2RAs develop loss of efficacy in antisecretory potency -Might occur as early as second dose of H2RA increasing to 29 days of dosing Tolerance phenomenon is not overcome by an increase in dosage
Observed Adverse Events with PPI • PPI Adverse Events • Lansoprazole Headache (3%) Constipation (5%) Diarrhea,abdominal pain nausea • Omeprazole Headache (2.4% Rash(1.1%) Diarrhea(1.9%) Abdominal pain, nausea constipation
Observed Adverse Events with PPIs • No reported long-term side effects with PPIs • Adverse events reported with PPIs are similar to those reported with placebo Scott LJ et al.Drugs.2002;62:1503. Gold b. Pediatric Drugs. 2002;4:673 Rudolph CD., et al. Jpediatr GassstroenterolNutr.2001;32:S1 Klinkenberg- KknolEC, et al.Gastroenterology2000;118(4):661. l
The Role of Metoclopramide in the Treatment of GERD • High incidence of adverse events • Medication crosses the blood brain barrier Tardive dyskinesia (amy be irrever- sible) Lethargy Irritability • Evidence suggests poor clinical efficacy
Children at Risk for Long-term Complications of GERD • Asthma • Cystic fibrosis • Esophageal atresia • Down’s syndrome • Erosive esophagitis • Neurologic impairment
Asthmatic Children withoutGERD Symptoms • Indications for work-up Radiographic evidence of recurrent pneumonia Nocturnal asthma that occurs more than once weekly Continuous oral or high-dose inhaled corticosteroids
Asthmatic Children without GERD Symptoms Indications for work-up (continuation) More than 2 courses of oral corticosteroid required per year Exacerbation of asthma whenever medications are decreased
Complications of GERD • Esophagitis • Peptic Stricture • Failure to thrive • Pulmonary/ENT disease • Barrett’s esophagus • Adenocarcinoma
Considerations for Testing or Referral to a GI Specialist • No response to PPI therapy • Patient is unable to be weaned from medical therapy or has significant side effects • Signs of complications or severe disease -Alarm signs or sxs present(eg.blood loss,Significant growth problems and -Life threatening issues (eg.respiratory)
SUMMARY Pediatric reflux is a common condition in children Children less than 18 months old with GER rarely develop GERD GERD in children presents as a variety of symptoms
Summary • Complications of GERD include: -Asthma -Erosive esophagitis -Stricture -Barrett’s esophagus -Adenocarcinoma
SUMMARY • Early detection and intervention may prevent life-long complications • An empiric trial of acid suppression can be diagnostic and therapeutic • PPI therapy is the most effective for GERD symptom relief and esophageal healing
SUMMARY • Children with cystic fibrosis, esophageal atresia, or neurologic impairment may be at greater risk of complications of GERD • Safe and effective treatments exist for long-term suppression of acid
Summary • Children less than 18 months old with GER rarely develop GERD • Complications of GERD : -Asthma Adenocarcinoma -Erosive esophagitis -Stricture -Barrett’s esophagus
Summary • Children with cystic fibrosis, esophageal atresia,or neurologic impairment may be at greater risk for complications of GERD • Safe and effective treatments are available for long term acid suppression and should be used